Summary
Murine models of systemic lupus erythematosus provide fertile research systems for the pathogenesis and therapy of systemic autoimmune disease. Their phenotypes span the broad range of clinical manifestations of human lupus and consist of both spontaneous and experimentally induced disease in both inbred and targeted mutant animals. This chapter contrasts the clinical characteristics of these various models, providing an outline for the use and analysis of these in vivo autoimmune systems.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Boumpas, D. T., Austin, H. A., 3rd, Fessler, B. J., Balow, J. E., Klippel, J. H., and Lockshin, M. D. (1995) Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann. Intern. Med. 122, 940–950.
Boumpas, D. T., Fessler, B. J., Austin, H. A., 3rd, Balow, J. E., Klippel, J. H., and Lockshin, M. D. (1995) Systemic lupus erythematosus: emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis. Ann. Intern. Med. 123, 42–53.
Burkhardt, H. and Kalden, J. R. (1997) Animal models of autoimmune diseases. Rheumatol. Int. 17, 91–99.
Stoll, M. L. and Gavalchin, J. (2000) Systemic lupus erythematosus-messages from experimental models. Rheumatology 39, 18–27.
Jones, D. R. (1993) Canine systemic lupus erythematosus: new insights and their implications. J. Comp. Pathol. 108, 215–228.
Lusson, D., Billiemaz, B., and Chabanne, J. L. (1999) Circulating lupus anticoagulant and probable systemic lupus erythematosus in a cat. J. Feline Med. Surg. 1, 193–196.
Theofilopoulos, A. N. and Dixon, F. J. (1985) Murine models of systemic lupus erythematosus. Adv. Immunol. 37, 269–390.
Cohen, P. L. and Eisenberg, R. A. (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243–269.
Brey, R. L., Sakic, B., Szechtman, H., and Denburg, J. A. (1997) Animal models for nervous system disease in systemic lupus erythematosus. Ann. N. Y. Acad. Sci. 823, 97–106.
Furukawa, F. (1997) Animal models of cutaneous lupus erythematosus and lupus erythematosus photosensitivity. Lupus 6, 193–202.
Peng, S. L. and Craft, J. (1997) The regulation of murine lupus. Ann. N. Y. Acad. Sci. 815, 128–138.
Scofield, R. H. and James, J. A. (1999) Immunization as a model for systemic lupus erythematosus. Sem. Arthritis Rheum. 29, 140–147.
Izui, S., Ibnou-Zekri, N., Fossati-Jimack, L., and Iwamoto, M. (2000) Lessons from BXSB and related mouse models. Int. Rev. Immunol. 19, 447–472.
Kono, D. H. and Theofilopoulos, A. N. (2000) Genetics of systemic autoimmunity in mouse models of lupus. Int. Rev. Immunol. 19, 367–387.
Nose, M., Nishihara, M., and Fujii, H. (2000) Genetic basis of the complex pathological manifestations of collagen disease: lessons from MRL/lpr and related mouse models. Int. Rev. Immunol. 19, 473–498.
Shlomchik, M. J., Craft, J. E., and Mamula, M. J. (2001) From T to B and back again: positive feedback in systemic autoimmune disease. Nat. Rev. Immunol. 1, 147–153.
Bielschowsky, M., Helyer, B. J., and Howie, J. B. (1959) Spontaneous haemolytic anemia in mice of the NZB/BL strain. Proc. Univ. Otago Med. Sch. 37, 9.
Bielschowsky, M. and Goodall, C. M. (1970) Origin of inbred NZ mouse strains. Cancer Res. 30, 834–836.
Hall, W. H. and Simpson, L. O. (1975) The origins of some hitherto undescribed inbred mouse strains. Lab. Animals 9, 139–142.
Beck, J. A., Lloyd, S., Hafezparast, M., Lennon-Pierce, M., Eppig, J. T., Festing, M. F., et al. (2000) Genealogies of mouse inbred strains. Nat. Genet. 24, 23–25.
Jackson Laboratory website, http://jaxmice.jax.org/jaxmice-cgi/jaxmicedb.cgi?objtype=pricedetail&stock=001058&dest=N.
Burnet, F. M. and Holmes, M. C. (1965) The natural history of the NZB/NZW F1 hybrid mouse: a laboratory model of systemic lupus erythematosus. Aust. Ann. Med. 14, 185–191.
Chiang, B. L., Bearer, E., Ansari, A., Dorshkind, K., and Gershwin, M. E. (1990) The BM12 mutation and autoantibodies to dsDNA in NZB.H-2bm12 mice. J. Immunol. 145, 94–101.
Rudofsky, U. H., Evans, B. D., Balaban, S. L., Mottironi, V. D., and Gabrielsen, A. E. (1993) Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization. Lab. Invest. 68, 419–426.
Morel, L., Rudofsky, U. H., Longmate, J. A., Schiffenbauer, J., and Wakeland, E. K. (1994) Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1, 219–229.
Helyer, B. J. and Howie, J. B. (1963) Renal disease associated with positive lupus erythematosus test in a cross-bred strain of mice. Nature 197, 197.
Hicks, J. D. and Burnet, F. M. (1966) Renal lesions in the “auto-immune” mouse strains NZB and F1 NZBxNZW. J. Pathol. Bacteriol. 91, 467–476.
Hicks, J. D. (1966) Vascular changes in the kidneys of NZB mice and F1 NZBxNZW hybrids. J. Pathol. Bacteriol. 91, 479–486.
Russell, P. J., Hicks, J. D., and Burnet, F. M. (1966) Cyclophosphamide treatment of kidney disease in (NZB × NZW) F1 mice. Lancet 1, 1280–1284.
Miyasato, F., Manaligod, J. R., and Pollak, V. E. (1967) Auto-immune disease in NZB and NZB-NZW F1 mice. Natural history and pathology. Arch. Pathol. Lab. Med. 83, 20–30.
Russell, P. J. and Hicks, J. D. (1968) Cyclophosphamide treatment of renal disease in (NZB × NZW) F1 hybrid mice. Lancet 1, 440–441.
Deshmukh, U. S., Lewis, J. E., Gaskin, F., Dhakephalkar, P. K., Kannapell, C. C., Waters, S. T., et al. (2000) Ro60 peptides induce antibodies to similar epitopes shared among lupus-related autoantigens. J. Immunol. 164, 6655–6661.
Monneaux, F., Dumortier, H., Steiner, G., Briand, J. P., and Muller, S. (2001) Murine models of systemic lupus erythematosus: B and T cell responses to spliceosomal ribonucleoproteins in MRL/Fas(lpr) and (NZB × NZW) F1 lupus mice. Int. Immunol. 13, 1155–1163.
Suen, J. L., Wu, C. H., Chen, Y. Y., Wu, W. M., and Chiang, B. L. (2001) Characterization of self-T-cell response and antigenic determinants of U1A protein with bone marrow-derived dendritic cells in NZB × NZW F1 mice. Immunology 103, 301–309.
Matsuura, E., Igarashi, Y., Yasuda, T., Triplett, D. A., and Koike, T. (1994) Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179, 457–462.
Haruta, K., Kobayashi, S., Hirose, S., Horiai, A., Ohyanagi, M., Tanaka, M., et al. (1998) Monoclonal anti-cardiolipin antibodies from New Zealand black × New Zealand white F1 mice react to thrombomodulin. J. Immunol. 160, 253–258.
Boros, P., Chen, J. M., Bona, C., and Unkeless, J. C. (1990) Autoimmune mice make anti-Fcγ receptor antibodies. J. Exp. Med. 171, 1581–1595.
Eilat, D., Schechter, A. N., and Steinberg, A. D. (1976) Antibodies to native tRNA in NZB/NZW mice. Nature 259, 141–143.
Boackle, S. A., Holers, V. M., Chen, X., Szakonyi, G., Karp, D. R., Wakeland, E. K., et al. (2001) Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15, 775–785.
Rozzo, S. J., Allard, J. D., Choubey, D., Vyse, T. J., Izui, S., Peltz, G., et al. (2001) Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity 15, 435–443.
Hirose, S., Nagasawa, R., Sekikawa, I., Hamaoki, M., Ishida, Y., Sato, H., et al. (1983) Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB × NZW) F1 mice. J. Exp. Med. 158, 228–233.
Kotzin, B. L. and Palmer, E. (1987) The contribution of NZW genes to lupus-like disease in (NZB × NZW) F1 mice. J. Exp. Med. 165, 1237–1251.
Schiffenbauer, J., McCarthy, D. M., Nygard, N. R., Woulfe, S. L., Didier, D. K., and Schwartz, B. D. (1989) A unique sequence of the NZW I-Eβ chain and its possible contribution to autoimmunity in the (NZB × NZW) F1 mouse. J. Exp. Med. 170, 971–984.
Babcock, S. K., Appel, V. B., Schiff, M., Palmer, E., and Kotzin, B. L. (1989) Genetic analysis of the imperfect association of H-2 haplotype with lupus-like autoimmune disease. Proc. Natl. Acad. Sci. USA 86, 7552–7555.
Ibnou-Zekri, N., Iwamoto, M., Fossati, L., McConahey, P. J., and Izui, S. (1997) Role of the major histocompatibility complex class II Ea gene in lupus susceptibility in mice. Proc. Natl. Acad. Sci. U S A 94, 14,654–14,659.
Vyse, T. J., Rozzo, S. J., Drake, C. G., Appel, V. B., Lemeur, M., Izui, S., et al. (1998) Contributions of Ea(z) and Eb(z) MHC genes to lupus susceptibility in New Zealand mice. J. Immunol. 160, 2757–2766.
Vyse, T. J., Halterman, R. K., Rozzo, S. J., Izui, S., and Kotzin, B. L. (1999) Control of separate pathogenic autoantibody responses marks MHC gene contributions to murine lupus. Proc. Natl. Acad. Sci. USA 96, 8098–8103.
Jacob, C. O. and McDevitt, H. O. (1988) Tumour necrosis factor-α in murine autoimmune “lupus” nephritis. Nature 331, 356–358.
Jongeneel, C. V., Acha-Orbea, H., and Blankenstein, T. (1990) A polymorphic microsatellite in the tumor necrosis factor α promoter identifies an allele unique to the NZW mouse strain. J. Exp. Med. 171, 2141–2146.
Knight, J. G. and Adams, D. D. (1978) Three genes for lupus nephritis in NZB × NZW mice. J. Exp. Med. 147, 1653–1660.
Ozaki, S., Honda, H., Maruyama, N., Hirose, S., Hamaoki, M., Sato, H., et al. (1983) Genetic regulation of erythrocyte autoantibody production in New Zealand black mice. Immunogenetics 18, 241–254.
Drake, C. G., Babcock, S. K., Palmer, E., and Kotzin, B. L. (1994) Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB × NZW) F1 mice. Proc. Natl. Acad. Sci. USA 91, 4062–4066.
Kono, D. H., Burlingame, R. W., Owens, D. G., Kuramochi, A., Balderas, R. S., Balomenos, D., et al. (1994) Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. USA 91, 10,168–10,172.
Rahman, Z. S., Tin, S. K., Buenaventura, P. N., Ho, C. H., Yap, E. P., Yong, R. Y., et al. (2002) A novel susceptibility locus on chromosome 2 in the (New Zealand black × New Zealand white) F1 hybrid mouse model of systemic lupus erythematosus. J. Immunol. 168, 3042–3049.
Adelman, N. E., Watling, D. L., and McDevitt, H. O. (1983) Treatment of (NZB × NZW) F1 disease with anti-I-A monoclonal antibodies. J. Exp. Med. 158, 1350–1355.
Wofsy, D. and Seaman, W. E. (1985) Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161, 378–391.
Datta, S. K., Patel, H., and Berry, D. (1987) Induction of a cationic shift in IgG anti-DNA autoantibodies. Role of T helper cells with classical and novel phenotypes in three murine models of lupus nephritis. J. Exp. Med. 165, 1252–1268.
Tillman, D. M., Jou, N. T., Hill, R. J., and Marion, T. N. (1992) Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB × NZW) F1 mice. J. Exp. Med. 176, 761–779.
Friedmann, D., Yachimovich, N., Mostoslavsky, G., Pewzner-Jung, Y., Ben-Yehuda, A., Rajewsky, K., et al. (1999) Production of high affinity autoantibodies in autoimmune New Zealand black/New Zealand white F1 mice targeted with an anti-DNA heavy chain. J. Immunol. 162, 4406–4416.
Kaliyaperumal, A., Mohan, C., Wu, W., and Datta, S. K. (1996) Nucleosomal peptide epitopes for nephritis-inducing T helper cells of murine lupus. J. Exp. Med. 183, 2459–2469.
Kaliyaperumal, A., Michaels, M. A., and Datta, S. K. (1999) Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells. J. Immunol. 162, 5775–5783.
Kaliyaperumal, A., Michaels, M. A., and Datta, S. K. (2002) Naturally processed chromatin peptides reveal a major autoepitope that primes pathogenic T and B cells of lupus. J. Immunol. 168, 2530–2537.
Wang, Y., Hu, Q., Madri, J. A., Rollins, S. A., Chodera, A., and Matis, L. A. (1996) Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc. Natl. Acad. Sci. USA 93, 8563–8568.
Clynes, R., Dumitru, C., and Ravetch, J. V. (1998) Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279, 1052–1054.
Pritchard, N. R., Cutler, A. J., Uribe, S., Chadban, S. J., Morley, B. J., and Smith, K. G. (2000) Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcγRII. Curr. Biol. 10, 227–230.
Finck, B. K., Linsley, P. S., and Wofsy, D. (1994) Treatment of murine lupus with CTLA4Ig. Science 265, 1225–1227.
Early, G. S., Zhao, W., and Burns, C. M. (1996) Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black × New Zealand white mice. Response correlates with the absence of an anti-antibody response. J. Immunol. 157, 3159–3164.
Mihara, M., Tan, I., Chuzhin, Y., Reddy, B., Budhai, L., Holzer, A., et al. (2000) CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus. J. Clin. Invest. 106, 91–101.
Daikh, D. I. and Wofsy, D. (2001) Cutting edge: reversal of murine lupus nephritis with CTLA4Ig and cyclophosphamide. J. Immunol. 166, 2913–2916.
Wang, X., Huang, W., Mihara, M., Sinha, J., and Davidson, A. (2002) Mechanism of action of combined short-term CTLA4Ig and anti-CD40 ligand in murine systemic lupus erythematosus. J. Immunol. 168, 2046–2053.
Gilkeson, G. S., Pippen, A. M., and Pisetsky, D. S. (1995) Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. J. Clin. Invest. 95, 1398–1402.
Gilkeson, G. S., Ruiz, P., Pippen, A. M., Alexander, A. L., Lefkowith, J. B., and Pisetsky, D. S. (1996) Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J. Exp. Med. 183, 1389–1397.
Riemekasten, G., Kawald, A., Weiss, C., Meine, A., Marell, J., Klein, R., et al. (2001) Strong acceleration of murine lupus by injection of the SmD1(83–119) peptide. Arthritis Rheum. 44, 2435–2445.
Hahn, B. H. and Ebling, F. M. (1983) Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies. J. Clin. Invest. 71, 1728–1736.
Singh, R. R., Kumar, V., Ebling, F. M., Southwood, S., Sette, A., Sercarz, E. E., et al. (1995) T cell determinants from autoantibodies to DNA can upregulate autoimmunity in murine systemic lupus erythematosus. J. Exp. Med. 181, 2017–2027.
Singh, R. R., Ebling, F. M., Sercarz, E. E., and Hahn, B. H. (1995) Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. J. Clin. Invest. 96, 2990–2996.
Hahn, B. H., Singh, R. R., Wong, W. K., Tsao, B. P., Bulpitt, K., and Ebling, F. M. (2001) Treatment with a consensus peptide based on amino acid sequences in autoantibodies prevents T cell activation by autoantigens and delays disease onset in murine lupus. Arthritis Rheum. 44, 432–441.
Beger, E., Deocharan, B., Edelman, M., Erblich, B., Gu, Y., and Putterman, C. (2002) A peptide DNA surrogate accelerates autoimmune manifestations and nephritis in lupus-prone mice. J. Immunol. 168, 3617–3626.
Jacob, C. O., van der Meide, P. H., and McDevitt, H. O. (1987) In vivo treatment of (NZB × NZW) F1 lupus-like nephritis with monoclonal antibody to γ interferon. J. Exp. Med. 166, 798–803.
Ozmen, L., Roman, D., Fountoulakis, M., Schmid, G., Ryffel, B., and Garotta, G. (1995) Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-γ receptor inhibits the onset of glomerulonephritis. Eur. J. Immunol. 25, 6–12.
Haas, C., Ryffel, B., and Le Hir, M. (1998) IFN-γ receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB × NZW) F1 mice. J. Immunol. 160, 3713–3718.
Kontoyiannis, D. and Kollias, G. (2000) Accelerated autoimmunity and lupus nephritis in NZB mice with an engineered heterozygous deficiency in tumor necrosis factor. Eur. J. Immunol. 30, 2038–2047.
Altman, A., Theofilopoulos, A. N., Weiner, R., Katz, D. H., and Dixon, F. J. (1981) Analysis of T cell function in autoimmune murine strains. Defects in production and responsiveness to interleukin 2. J. Exp. Med. 154, 791–808.
Nakajima, A., Hirose, S., Yagita, H., and Okumura, K. (1997) Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice. J. Immunol. 158, 1466–1472.
Santiago, M. L., Fossati, L., Jacquet, C., Muller, W., Izui, S., and Reininger, L. (1997) Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J. Exp. Med. 185, 65–70.
Finck, B. K., Chan, B., and Wofsy, D. (1994) Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. J. Clin. Invest. 94, 585–591.
Ishida, H., Muchamuel, T., Sakaguchi, S., Andrade, S., Menon, S., and Howard, M. (1994) Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J. Exp. Med. 179, 305–310.
Goldings, E. A., Cohen, P. L., McFadden, S. F., Ziff, M., and Vitetta, E. S. (1980) Defective B cell tolerance in adult (NZB × NZW) F1 mice. J. Exp. Med. 152, 730–735.
Brooks, M. S. and Aldo-Benson, M. (1986) Defects in antigen-specific immune tolerance in continuous B cell lines from autoimmune mice. J. Clin. Invest. 78, 784–789.
Klinman, D. M. and Steinberg, A. D. (1987) Systemic autoimmune disease arises from polyclonal B cell activation. J. Exp. Med. 165,, 1755–1760.
Klinman, D. M. (1990) Polyclonal B cell activation in lupus-prone mice precedes and predicts the development of autoimmune disease. J. Clin. Invest. 86, 1249–1254.
Reininger, L., Radaszkiewicz, T., Kosco, M., Melchers, F., and Rolink, A. G. (1992) Development of autoimmune disease in SCID mice populated with long-term “in vitro” proliferating (NZB × NZW) F1 pre-B cells. J. Exp. Med. 176, 1343–1353.
Murakami, M., Yoshioka, H., Shirai, T., Tsubata, T., and Honjo, T. (1995) Prevention of autoimmune symptoms in autoimmune-prone mice by elimination of B-1 cells. Int. Immunol. 7, 877–882.
Reininger, L., Winkler, T. H., Kalberer, C. P., Jourdan, M., Melchers, F., and Rolink, A. G. (1996) Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB × NZW) F1 mice. J. Exp. Med. 184, 853–861.
Cassese, G., Lindenau, S., de Boer, B., Arce, S., Hauser, A., Riemekasten, G., et al. (2001) Inflamed kidneys of NZB/W mice are a major site for the homeostasis of plasma cells. Eur. J. Immunol. 31, 2726–2732.
Wellmann, U., Letz, M., Schneider, A., Amann, K., and Winkler, T. H. (2001) An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB × NZW) F1 mice. Int. Immunol. 13, 1461–1469.
Ishikawa, S., Sato, T., Abe, M., Nagai, S., Onai, N., Yoneyama, H., et al. (2001) Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193, 1393–1402.
Zeng, D., Lee, M. K., Tung, J., Brendolan, A., and Strober, S. (2000) Cutting edge: a role for CD1 in the pathogenesis of lupus in NZB/NZW mice. J. Immunol. 164, 5000–5004.
Murphy, E. D. (1981) Lymphoproliferation (lpr) and other single-locus models for murine lupus, in Immunologic Defects in Laboratory Animals (Gershwin, M. E., and Merchant, B., eds.), Plenum Press, New York, Vol. 1, pp. 143–173.
Izui, S., McConahey, P. J., and Dixon, F. J. (1978) Increased spontaneous polyclonal activation of B lymphocytes in mice with spontaneous autoimmune disease. J. Immunol. 121, 2213–2219.
Andrews, B. S., Eisenberg, R. A., Theofilopoulos, A. N., Izui, S., Wilson, C. B., McConahey, P. J., et al. (1978) Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J. Exp. Med. 148, 1198–1215.
Dixon, F. J., Andrews, B. S., Eisenberg, R. A., McConahey, P. J., Theofilopoulos, A. N., and Wilson, C. B. (1978) Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthritis Rheum. 21, S64–S67.
Murphy, E. D. and Roths, J. B. (1976) A single gene model for massive lyphoproliferation with immune complex disease in new mouse strain MRL. Proc. 16th Int. Cong. Hematol., 69.
Murphy, E. D. and Roths, J. B. (1978) New inbred strains. Mouse News Lett. 58, 51.
Burlingame, R. W., Rubin, R. L., Balderas, R. S., and Theofilopoulos, A. N. (1993) Genesis and evolution of antichromatin autoantibodies in murine lupus implicates T-dependent immunization with self antigen. J. Clin. Invest. 91, 1687–1696.
Hang, L., Slack, J. H., Amundson, C., Izui, S., Theofilopoulos, A. N., and Dixon, F. J. (1983) Induction of murine autoimmune disease by chronic polyclonal B cell activation. J. Exp. Med. 157, 874–883.
Vratsanos, G. S., Jung, S., Park, Y. M., and Craft, J. (2001) CD4(+) T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus. J. Exp. Med. 193, 329–337.
Eisenberg, R. A., Craven, S. Y., Warren, R. W., and Cohen, P. L. (1987) Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest. 80, 691–697.
Shlomchik, M. J., Marshak-Rothstein, A., Wolfowicz, C. B., Rothstein, T. L., and Weigert, M. G. (1987) The role of clonal selection and somatic mutation in autoimmunity. Nature 328, 805–811.
Shlomchik, M. J., Aucoin, A. H., Pisetsky, D. S., and Weigert, M. G. (1987) Structure and function of anti-DNA autoantibodies derived from a single autoimmune mouse. Proc. Natl. Acad. Sci. USA 84, 9150–9154.
Shlomchik, M., Mascelli, M., Shan, H., Radic, M. Z., Pisetsky, D., Marshak-Rothstein, A., et al. (1990) Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. J. Exp. Med. 171, 265–292.
Bloom, D. D., Davignon, J. L., Retter, M. W., Shlomchik, M. J., Pisetsky, D. S., Cohen, P. L., et al. (1993) V region gene analysis of anti-Sm hybridomas from MRL/Mp-lpr/lpr mice. J. Immunol. 150, 1591–1610.
Bloom, D. D., Davignon, J. L., Cohen, P. L., Eisenberg, R. A., and Clarke, S. H. (1993) Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice. J. Immunol. 150, 1579–1590.
Ishigatsubo, Y., Igarashi, T., Ohno, S., Ueda, A., Okubo, T., and Klinman, D. M. (1993) Cross-reactivity of IgM-and IgG-secreting B cells in autoimmune mice. Arthritis Rheum. 36, 1003–1006.
Klinman, D. M., Dellacqua, D. K., Conover, J., and Huppi, K. (1993) VH family utilization by IgG anti-DNA-secreting lymphocytes derived from autoimmune MRL-lpr/lpr mice. Arthritis Rheum. 36, 561–568.
Fatenejad, S., Brooks, W., Schwartz, A., and Craft, J. (1994) Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. J. Immunol. 152, 5523–5531.
Kita, Y., Sumida, T., Iwamoto, I., Yoshida, S., and Koike, T. (1994) V gene analysis of anti-cardiolipin antibodies from (NZW × BXSB) F1 mice. Immunology 82, 494–501.
Shan, H., Shlomchik, M. J., Marshak-Rothstein, A., Pisetsky, D. S., Litwin, S., and Weigert, M. G. (1994) The mechanism of autoantibody production in an autoimmune MRL/lpr mouse. J. Immunol. 153, 5104–5120.
Retter, M. W., Cohen, P. L., Eisenberg, R. A., and Clarke, S. H. (1996) Both Sm and DNA are selecting antigens in the anti-Sm B cell response in autoimmune MRL/lpr mice. J. Immunol. 156, 1296–1306.
Brard, F., Shannon, M., Prak, E. L., Litwin, S., and Weigert, M. (1999) Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J. Exp. Med. 190, 691–704.
Fatenejad, S., Mamula, M. J., and Craft, J. (1993) Role of intermolecular/intrastructural B-and T-cell determinants in the diversification of autoantibodies to ribonucleoprotein particles. Proc. Natl. Acad. Sci. USA 90, 12,010–12,014.
Scofield, R. H., Farris, A. D., Horsfall, A. C., and Harley, J. B. (1999) Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins. Arthritis Rheum. 42, 199–209.
Gay, D., Saunders, T., Camper, S., and Weigert, M. (1993) Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 177, 999–1008.
Klonowski, K. D., Primiano, L. L., and Monestier, M. (1999) Atypical VH-D-JH rearrangements in newborn autoimmune MRL mice. J. Immunol. 162, 1566–1572.
Klonowski, K. D. and Monestier, M. (2000) Heavy chain revision in MRL mice: a potential mechanism for the development of autoreactive B cell precursors. J. Immunol. 165, 4487–4493.
Roark, J. H., Kuntz, C. L., Nguyen, K. A., Mandik, L., Cattermole, M., and Erikson, J. (1995) B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice. J. Immunol. 154, 4444–4455.
Chen, C., Nagy, Z., Radic, M. Z., Hardy, R. R., Huszar, D., Camper, S. A., et al. (1995) The site and stage of anti-DNA B-cell deletion. Nature 373, 252–255.
Santulli-Marotto, S., Retter, M. W., Gee, R., Mamula, M. J., and Clarke, S. H. (1998) Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 8, 209–219.
Santulli-Marotto, S., Qian, Y., Ferguson, S., and Clarke, S. H. (2001) Anti-Sm B cell differentiation in Ig transgenic MRL/Mp-lpr/lpr mice: altered differentiation and an accelerated response. J. Immunol. 166, 5292–5299.
Ma, J., Xu, J., Madaio, M. P., Peng, Q., Zhang, J., Grewal, I. S., et al. (1996) Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses. J. Immunol. 157, 417–426.
Peng, S. L., Madaio, M. P., Hughes, D. P., Crispe, I. N., Owen, M. J., Wen, L., et al. (1996) Murine lupus in the absence of αβ T cells. J. Immunol. 156,, 4041–4049.
Peng, S. L., Madaio, M. P., Hayday, A. C., and Craft, J. (1996) Propagation and regulation of systemic autoimmunity by γδ T cells. J. Immunol. 157, 5689–5698.
Peng, S. L., Fatenejad, S., and Craft, J. (1996) Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic alpha beta T cell. Separation of autoantigen-specific and-nonspecific help. J. Immunol. 157, 5225–5230.
Chan, O. T., Madaio, M. P., and Shlomchik, M. J. (1999) The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169, 107–121.
Peng, S. L., Moslehi, J., and Craft, J. (1997) Roles of interferon-γ and interleukin-4 in murine lupus. J. Clin. Invest. 99, 1936–1946.
Balomenos, D., Rumold, R., and Theofilopoulos, A. N. (1998) Interferon-γ is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101, 364–371.
Schwarting, A., Wada, T., Kinoshita, K., Tesch, G., and Kelley, V. R. (1998) IFN-γ receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. J. Immunol. 161, 494–503.
Tesch, G. H., Maifert, S., Schwarting, A., Rollins, B. J., and Kelley, V. R. (1999) Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J. Exp. Med. 190, 1813–1824.
Sekine, H., Reilly, C. M., Molano, I. D., Garnier, G., Circolo, A., Ruiz, P., et al. (2001) Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J. Immunol. 166, 6444–6451.
Bao, L., Haas, M., Boackle, S. A., Kraus, D. M., Cunningham, P. N., Park, P., et al. (2002) Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice. J. Immunol. 168, 3601–3607.
Lloyd, C. M., Gonzalo, J. A., Salant, D. J., Just, J., and Gutierrez-Ramos, J. C. (1997) Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus. J. Clin. Invest. 100, 963–971.
Tada, Y., Nagasawa, K., Ho, A., Morito, F., Koarada, S., Ushiyama, O., et al. (1999) Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice. J. Immunol. 163, 3153–3159.
Kinoshita, K., Tesch, G., Schwarting, A., Maron, R., Sharpe, A. H., and Kelley, V. R. (2000) Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J. Immunol. 164, 6046–6056.
Liang, B., Kashgarian, M. J., Sharpe, A. H., and Mamula, M. J. (2000) Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. J. Immunol. 165, 3436–3443.
Jevnikar, A. M., Grusby, M. J., and Glimcher, L. H. (1994) Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179, 1137–1143.
Christianson, G. J., Blankenburg, R. L., Duffy, T. M., Panka, D., Roths, J. B., Marshak-Rothstein, A., et al. (1996) β2-Microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. J. Immunol. 156, 4932–4939.
Chan, O. T., Paliwal, V., McNiff, J. M., Park, S. H., Bendelac, A., and Shlomchik, M. J. (2001) Deficiency in β2-microglobulin, but not CD1, accelerates spontaneous lupus skin disease while inhibiting nephritis in MRLFas(lpr) nice: an example of disease regulation at the organ level. J. Immunol. 167, 2985–2990.
Watson, M. L., Rao, J. K., Gilkeson, G. S., Ruiz, P., Eicher, E. M., Pisetsky, D. S., et al. (1992) Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176, 1645–1656.
Gu, L., Weinreb, A., Wang, X. P., Zack, D. J., Qiao, J. H., Weisbart, R., et al. (1998) Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus. J. Immunol. 161, 6999–7006.
Vidal, S., Kono, D. H., and Theofilopoulos, A. N. (1998) Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J. Clin. Invest. 101, 696–702.
Nishihara, M., Terada, M., Kamogawa, J., Ohashi, Y., Mori, S., Nakatsuru, S., et al. (1999) Genetic basis of autoimmune sialadenitis in MRL/lpr lupus-prone mice: additive and hierarchical properties of polygenic inheritance. Arthritis Rheum. 42, 2616–2623.
Kamogawa, J., Terada, M., Mizuki, S., Nishihara, M., Yamamoto, H., Mori, S., et al. (2002) Arthritis in MRL/lpr mice is under the control of multiple gene loci with an allelic combination derived from the original inbred strains. Arthritis Rheum. 46, 1067–1074.
Kawase, E., Suemori, H., Takahashi, N., Okazaki, K., Hashimoto, K., and Nakatsuji, N. (1994) Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38, 385–390.
Goulet, J. L., Wang, C. Y., and Koller, B. H. (1997) Embryonic stem cell lines from MRL mice allow genetic modification in a murine model of autoimmune disease. J. Immunol. 159, 4376–4381.
Kelley, V. E. and Roths, J. B. (1985) Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 37, 220–229.
Eisenberg, R. A., Craven, S. Y., Fisher, C. L., Morris, S. C., Rapoport, R., Pisetsky, D. S., et al. (1989) The genetics of autoantibody production in MRL/lpr lupus mice. Clin. Exp. Rheumatol. 7, S35–S40.
Peng, S. L. and Craft, J. (1999) Lessons from knockout and transgenic lupus-prone mice, in Lupus: Molecular and Cellular Pathogenesis (Kammer, G. M. and Tsokos, G. C., eds.), Humana Press, Totowa, NJ, pp. 152–166.
Murphy, E. D. and Roths, J. B. (1979) A Y chromosome associated factor in strain BXSB producing accelerated autoimmunity and lymphoproliferation. Arthritis Rheum. 22, 1188–1194.
Morel, L., Croker, B. P., Blenman, K. R., Mohan, C., Huang, G., Gilkeson, G., et al. (2000) Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains. Proc. Natl. Acad. Sci. USA 97, 6670–6675.
Izui, S., Masuda, K., and Yoshida, H. (1984) Acute SLE in F1 hybrids between SB/Le and NZW mice; prominently enhanced formation of gp70 immune complexes by a Y chromosome-associated factor from SB/Le mice. J. Immunol. 132, 701–704.
Hudgins, C. C., Steinberg, R. T., Klinman, D. M., Reeves, M. J., and Steinberg, A. D. (1985) Studies of consomic mice bearing the Y chromosome of the BXSB mouse. J. Immunol. 134, 3849–3854.
Izui, S., Higaki, M., Morrow, D., and Merino, R. (1988) The Y chromosome from autoimmune BXSB/MpJ mice induces a lupus-like syndrome in (NZW × C57BL/6) F1 male mice, but not in C57BL/6 male mice. Eur. J. Immunol. 18, 911–915.
Hogarth, M. B., Slingsby, J. H., Allen, P. J., Thompson, E. M., Chandler, P., Davies, K. A., et al. (1998) Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J. Immunol. 161, 2753–2761.
Haywood, M. E., Hogarth, M. B., Slingsby, J. H., Rose, S. J., Allen, P. J., Thompson, E. M., et al. (2000) Identification of intervals on chromosomes 1, 3, and 13 linked to the development of lupus in BXSB mice. Arthritis Rheum. 43, 349–355.
Maibaum, M. A., Haywood, M. E., Walport, M. J., and Morley, B. J. (2000) Lupus susceptibility loci map within regions of BXSB derived from the SB/Le parental strain. Immunogenetics 51, 370–372.
Haywood, M. E., Vyse, T. J., McDermott, A., Thompson, E. M., Ida, A., Walport, M. J., et al. (2001) Autoantigen glycoprotein 70 expression is regulated by a single locus, which acts as a checkpoint for pathogenic anti-glycoprotein 70 autoantibody production and hence for the corresponding development of severe nephritis, in lupus-prone BXSB mice. J. Immunol. 167, 1728–1733.
Hahn, B. H. and Ebling, F. M. (1984) A public idiotypic determinant is present on spontaneous cationic IgG antibodies to DNA from mice of unrelated lupus-prone strains. J. Immunol. 133, 3015–3019.
Lawson, B. R., Koundouris, S. I., Barnhouse, M., Dummer, W., Baccala, R., Kono, D. H., et al. (2001) The role of αβ T cells and homeostatic T cell proliferation in Y-chromosome-associated murine lupus. J. Immunol. 167, 2354–2360.
Wofsy, D. (1986) Administration of monoclonal anti-T cell antibodies retards murine lupus in BXSB mice. J. Immunol. 136, 4554–4560.
Chu, E. B., Hobbs, M. V., Wilson, C. B., Romball, C. G., Linsley, P. S., and Weigle, W. O. (1996) Intervention of CD4+ cell subset shifts and autoimmunity in the BXSB mouse by murine CTLA4Ig. J. Immunol. 156, 1262–1268.
Adachi, Y., Inaba, M., Sugihara, A., Koshiji, M., Sugiura, K., Amoh, Y., et al. (1998) Effects of administration of monoclonal antibodies (anti-CD4 or anti-CD8) on the development of autoimmune diseases in (NZW × BXSB) F1 mice. Immunobiology 198, 451–464.
Kono, D. H., Balomenos, D., Park, M. S., and Theofilopoulos, A. N. (2000) Development of lupus in BXSB mice is independent of IL-4. J. Immunol. 164, 38–42.
Merino, R., Iwamoto, M., Fossati, L., Muniesa, P., Araki, K., Takahashi, S., et al. (1993) Prevention of systemic lupus erythematosus in autoimmune BXSB mice by a transgene encoding I-Eα chain. J. Exp. Med. 178, 1189–1197.
Prud’homme, G. J., Balderas, R. S., Dixon, F. J., and Theofilopoulos, A. N. (1983) B cell dependence on and response to accessory signals in murine lupus strains. J. Exp. Med. 157, 1815–1827.
Umland, S. P., Go, N. F., Cupp, J. E., and Howard, M. (1989) Responses of B cells from autoimmune mice to IL-5. J. Immunol. 142, 1528–1535.
Merino, R., Fossati, L., Lacour, M., and Izui, S. (1991) Selective autoantibody production by Yaa+ B cells in autoimmune Yaa(+)-Yaa-bone marrow chimeric mice. J. Exp. Med. 174, 1023–1029.
Decker, P., Le Moal, A., Briand, J. P., and Muller, S. (2000) Identification of a minimal T cell epitope recognized by antinucleosome Th cells in the C-terminal region of histone H4. J. Immunol. 165, 654–662.
Zhang, X., Smith, D. S., Guth, A., and Wysocki, L. J. (2001) A receptor presentation hypothesis for T cell help that recruits autoreactive B cells. J. Immunol. 166, 1562–1571.
Ghatak, S., Sainis, K., Owen, F. L., and Datta, S. K. (1987) T-cell-receptor β-and I-Aβ-chain genes of normal SWR mice are linked with the development of lupus nephritis in NZB × SWR crosses. Proc. Natl. Acad. Sci. USA 84, 6850–6853.
Xie, S., Chang, S., Yang, P., Jacob, C., Kaliyaperumal, A., Datta, S. K., et al. (2001) Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. J. Immunol. 167, 7141–7149.
Kalled, S. L., Cutler, A. H., Datta, S. K., and Thomas, D. W. (1998) Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J. Immunol. 160, 2158–2165.
Merino, R., Iwamoto, M., Gershwin, M. E., and Izui, S. (1994) The Yaa gene abrogates the major histocompatibility complex association of murine lupus in (NZB × BXSB) F1 hybrid mice. J. Clin. Invest. 94, 521–525.
Hang, L. M., Izui, S., and Dixon, F. J. (1981) (NZW × BXSB) F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction. J. Exp. Med. 154, 216–221.
Berden, J. H., Hang, L., McConahey, P. J., and Dixon, F. J. (1983) Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities. J. Immunol. 130, 1699–1705.
Oyaizu, N., Yasumizu, R., Miyama-Inaba, M., Nomura, S., Yoshida, H., Miyawaki, S., et al. (1988) (NZW × BXSB) F1 mouse. A new animal model of idiopathic thrombocytopenic purpura. J. Exp. Med. 167, 2017–2022.
Hashimoto, Y., Kawamura, M., Ichikawa, K., Suzuki, T., Sumida, T., Yoshida, S., et al. (1992) Anticardiolipin antibodies in NZW × BXSB F1 mice. A model of antiphospholipid syndrome. J. Immunol. 149, 1063–1068.
Mizutani, H., Kurata, Y., Kosugi, S., Shiraga, M., Kashiwagi, H., Tomiyama, Y., et al. (1995) Monoclonal anticardiolipin autoantibodies established from the (New Zealand white × BXSB) F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipoprotein. Arthritis Rheum. 38, 1382–1388.
Ida, A., Hirose, S., Hamano, Y., Kodera, S., Jiang, Y., Abe, M., et al. (1998) Multigenic control of lupus-associated antiphospholipid syndrome in a model of (NZW × BXSB) F1 mice. Eur. J. Immunol. 28, 2694–2703.
Ibnou-Zekri, N., Iwamoto, M., Gershwin, M. E., and Izui, S. (2000) Protection of murine lupus by the Ead transgene is MHC haplotype-dependent. J. Immunol. 164, 505–511.
Vidal, S., Gelpi, C., and Rodriguez-Sanchez, J. L. (1994) (SWR × SJL) F1 mice: a new model of lupus-like disease. J. Exp. Med. 179, 1429–1435.
Yu, M., Johnson, J. M., and Tuohy, V. K. (1996) A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183, 1777–1788.
Kinjoh, K., Kyogoku, M., and Good, R. A. (1993) Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis. Proc. Natl. Acad. Sci. USA 90, 3413–3417.
Jethwa, H. S., Nachman, P. H., Falk, R. J., and Jennette, J. C. (2000) False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies. Clin. Exp. Immunol. 121, 544–550.
Portanova, J. P. and Kotzin, B. L. (1988) Lupus-like autoimmunity in murine graft-vs-host disease. Concepts Immunopathol. 6, 119–140.
Silveira, P. A. and Baxter, A. G. (2001) The NOD mouse as a model of SLE. Autoimmunity 34, 53–64.
Anderson, P. N. and Potter, M. (1969) Induction of plasma cell tumours in BALB-c mice with 2,6,10,14-tetramethylpentadecane (pristane). Nature 222, 994–995.
Mock, B. A., Krall, M. M., and Dosik, J. K. (1993) Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. Proc. Natl. Acad. Sci. USA 90, 9499–9503.
Zhang, S., Ramsay, E. S., and Mock, B. A. (1998) Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. Proc. Natl. Acad. Sci. USA 95, 2429–2434.
Kovalchuk, A. L., Kim, J. S., Park, S. S., Coleman, A. E., Ward, J. M., Morse, H. C., 3rd, et al. (2002) IL-6 transgenic mouse model for extraosseous plasmacytoma. Proc. Natl. Acad. Sci. USA 99, 1509–1514.
Potter, M. and Wax, J. S. (1981) Genetics of susceptibility to pristane-induced plasmacytomas in BALB/cAn: reduced susceptibility in BALB/cJ with a brief description of pristane-induced arthritis. J. Immunol. 127, 1591–1595.
Wooley, P. H., Seibold, J. R., Whalen, J. D., and Chapdelaine, J. M. (1989) Pristane-induced arthritis. The immunologic and genetic features of an experimental murine model of autoimmune disease. Arthritis Rheum. 32, 1022–1030.
Beech, J. T., Siew, L. K., Ghoraishian, M., Stasiuk, L. M., Elson, C. J., and Thompson, S. J. (1997) CD4+ Th2 cells specific for mycobacterial 65-kilodalton heat shock protein protect against pristane-induced arthritis. J. Immunol. 159, 3692–3697.
Thompson, S. J., Francis, J. N., Siew, L. K., Webb, G. R., Jenner, P. J., Colston, M. J., et al. (1998) An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis. J. Immunol. 160, 4628–4634.
Corrigall, V. M., Bodman-Smith, M. D., Fife, M. S., Canas, B., Myers, L. K., Wooley, P., et al. (2001) The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J. Immunol. 166, 1492–1498.
Satoh, M. and Reeves, W. H. (1994) Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J. Exp. Med. 180, 2341–2346.
Satoh, M., Kumar, A., Kanwar, Y. S., and Reeves, W. H. (1995) Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc. Natl. Acad. Sci. USA 92, 10,934–10,938.
Satoh, M., Langdon, J. J., Hamilton, K. J., Richards, H. B., Panka, D., Eisenberg, R. A., et al. (1996) Distinctive immune response patterns of human and murine autoimmune sera to U1 small nuclear ribonucleoprotein C protein. J. Clin. Invest. 97, 2619–2626.
Satoh, M., Richards, H. B., Shaheen, V. M., Yoshida, H., Shaw, M., Naim, J. O., et al. (2000) Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin. Exp. Immunol. 121, 399–405.
Richards, H. B., Satoh, M., Jennette, J. C., Croker, B. P., Yoshida, H., and Reeves, W. H. (2001) Interferon-γ is required for lupus nephritis in mice treated with the hydrocarbon oil pristane. Kidney Int. 60, 2173–2180.
Richards, H. B., Satoh, M., Shaw, M., Libert, C., Poli, V., and Reeves, W. H. (1998) Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J. Exp. Med. 188, 985–990.
Satoh, M., Weintraub, J. P., Yoshida, H., Shaheen, V. M., Richards, H. B., Shaw, M., et al. (2000) Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus. J. Immunol. 165, 1036–1043.
Satoh, M., Hamilton, K. J., Ajmani, A. K., Dong, X., Wang, J., Kanwar, Y. S., et al. (1996) Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J. Immunol. 157, 3200–3206.
Morse, H. C., 3rd, Riblet, R., Asofsky, R., and Weigert, M. (1978) Plasmacytomas of the NZB mouse. J. Immunol. 121, 1969–1972.
Byrd, L. G., McDonald, A. H., Gold, L. G., and Potter, M. (1991) Specific pathogen-free BALB/cAn mice are refractory to plasmacytoma induction by pristane. J. Immunol. 147, 3632–3637.
Mendlovic, S., Brocke, S., Shoenfeld, Y., Ben-Bassat, M., Meshorer, A., Bakimer, R., et al. (1988) Induction of a systemic lupus erythematosus-like disease in mice by a common human anti-DNA idiotype. Proc. Natl. Acad. Sci. USA 85, 2260–2264.
Blank, M., Cohen, J., Toder, V., and Shoenfeld, Y. (1991) Induction of anti-phospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anti-cardiolipin antibodies. Proc. Natl. Acad. Sci. U S A 88, 3069–3073.
Blank, M., Krause, I., Ben-Bassat, M., and Shoenfeld, Y. (1992) Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype. J. Autoimmun. 5, 495–509.
Shoenfeld, Y. and Ziporen, L. (1998) Lessons from experimental APS models. Lupus 7, S158–S161.
Waisman, A., Ruiz, P. J., Israeli, E., Eilat, E., Konen-Waisman, S., Zinger, H., et al. (1997) Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody. Proc. Natl. Acad. Sci. USA 94, 4620–4625.
Eilat, E., Dayan, M., Zinger, H., and Mozes, E. (2001) The mechanism by which a peptide based on complementarity-determining region-1 of a pathogenic anti-DNA auto-Ab ameliorates experimental systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 98, 1148–1153.
Mozes, E., Kohn, L. D., Hakim, F., and Singer, D. S. (1993) Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science 261, 91–93.
Segal, R., Dayan, M., Zinger, H., and Mozes, E. (2001) Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFα monoclonal antibody and by pentoxiphylline. Lupus 10, 23–31.
Isenberg, D. A., Katz, D., Le Page, S., Knight, B., Tucker, L., Maddison, P., et al. (1991) Independent analysis of the 16/6 idiotype lupus model. A role for an environmental factor? J. Immunol. 147, 4172–4177.
Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314–317.
Adachi, M., Watanabe-Fukunaga, R., and Nagata, S. (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA 90, 1756–1760.
Chu, J. L., Drappa, J., Parnassa, A., and Elkon, K. B. (1993) The defect in Fas mRNA expression in MRL/lpr mice is associated with insertion of the retrotransposon, ETn. J. Exp. Med. 178, 723–730.
Wu, J., Zhou, T., He, J., and Mountz, J. D. (1993) Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. Exp. Med. 178, 461–468.
Roths, J. B., Murphy, E. D., and Eicher, E. M. (1984) A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159, 1–20.
Lynch, D. H., Watson, M. L., Alderson, M. R., Baum, P. R., Miller, R. E., Tough, T., et al. (1994) The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1, 131–136.
Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., et al. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969–976.
Matsuzawa, A., Moriyama, T., Kaneko, T., Tanaka, M., Kimura, M., Ikeda, H., et al. (1990) A new allele of the lpr locus, lprcg, that complements the gld gene in induction of lymphadenopathy in the mouse. J. Exp. Med. 171, 519–531.
Kimura, M., Mohri, H., Shimada, K., Wakabayashi, T., Kanai, Y., and Matsuzawa, A. (1990) Serological and histological characterization of the new mutant strain of lpr mice, CBA/KlJms-lprcg/lprcg. Clin. Exp. Immunol. 79, 123–129.
Kimura, M., Katagiri, T., Kikuchi, Y., Shimada, K., Nariuchi, H., Wakabayashi, T., et al. (1991) Role of bone marrow cells in autoantibody production and lymphoproliferation in the novel mutant strain of mice, CBA/KlJms-lprcg/lprcg. Eur. J. Immunol. 21, 63–69.
Kimura, M., Ikeda, H., Katagiri, T., and Matsuzawa, A. (1991) Characterization of lymphoproliferation induced by interactions between lprcg and gld genes. Cell. Immunol. 134, 359–369.
Matsuzawa, A., Kimura, M., Muraiso, T., Kominami, R., and Katagiri, T. (1991) Genotype-restricted lymphoproliferation in autoimmune lpr mice. Eur. J. Immunol. 21, 1535–1542.
Kimura, M., Ogata, Y., Shimada, K., Moriyama, T., and Matsuzawa, A. (1991) New mutant mice of autoimmunity, CBA/KiJms-lprcg/lprcg, that could link the lpr and gld genes. Autoimmunity 9, 359–361.
Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., et al. (1996) Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc. Natl. Acad. Sci. USA 93, 2131–2136.
Senju, S., Negishi, I., Motoyama, N., Wang, F., Nakayama, K. I., Nakayama, K., et al. (1996) Functional significance of the Fas molecule in naive lymphocytes. Int. Immunol. 8,423–431.
Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., et al. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935–946.
Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A., Debatin, K. M., Fischer, A., et al. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347–1349.
Drappa, J., Vaishnaw, A. K., Sullivan, K. E., Chu, J. L., and Elkon, K. B. (1996) Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335, 1643–1649.
Wu, J., Wilson, J., He, J., Xiang, L., Schur, P. H., and Mountz, J. D. (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J. Clin. Invest. 98, 1107–1113.
Wang, J., Zheng, L., Lobito, A., Chan, F. K., Dale, J., Sneller, M., et al. (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98, 47–58.
Roark, J. H., Kuntz, C. L., Nguyen, K. A., Caton, A. J., and Erikson, J. (1995) Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181, 1157–1167.
Mandik-Nayak, L., Seo, S. J., Sokol, C., Potts, K. M., Bui, A., and Erikson, J. (1999) MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 189, 1799–1814.
Seo, S. J., Fields, M. L., Buckler, J. L., Reed, A. J., Mandik-Nayak, L., Nish, S. A., et al. (2002) The impact of T helper and T regulatory cells on the regulation of anti-double-stranded DNA B cells. Immunity 16, 535–546.
Theofilopoulos, A. N., Balderas, R. S., Gozes, Y., Aguado, M. T., Hang, L. M., Morrow, P. R., et al. (1985) Association of lpr gene with graft-vs-host disease-like syndrome. J. Exp. Med. 162, 1–18.
Kurien, B. T. and Scofield, R. H. (1999) Mouse urine collection using clear plastic wrap. Lab. Anim. 33, 83–86.
Kimura, M., Nagase, M., Hishida, A., and Honda, N. (1987) Intramesangial passage of mononuclear phagocytes in murine lupus glomerulonephritis. Am. J. Pathol. 127, 149–156.
Hoffsten, P. E., Hill, C. L., and Klahr, S. (1975) Studies of abluminuria and proteinuria in normal mice and mice with immune complex glomerulonephritis. J. Lab. Clin. Med. 86, 920–930.
Hem, A., Smith, A. J., and Solberg, P. (1998) Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab. Anim. 32, 364–368.
Furner, R. L. and Mellett, L. B. (1975) Mouse restraining chamber for tail-vein injection. Lab. Anim. Sci. 25, 648.
Durschlag, M., Wurbel, H., Stauffacher, M., and Von Holst, D. (1996) Repeated blood collection in the laboratory mouse by tail incision—modification of an old technique. Phys. Behav. 60, 1565–1568.
Hijmans, W., Radema, H., van Es, L., Feltkamp, T. E., van Loghem, J. J., and Schaap, O. L. (1969) Cryoglobulins in New Zealand black mice. Clin. Exp. Immunol. 4, 227–239.
Reininger, L., Berney, T., Shibata, T., Spertini, F., Merino, R., and Izui, S. (1990) Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc. Natl. Acad. Sci. USA 87, 10,038–10,042.
Dammacco, F., Sansonno, D., Piccoli, C., Tucci, F. A., and Racanelli, V. (2001) The cryoglobulins: an overview. Eur. J. Clin. Invest. 31, 628–638.
Peng, S. L. and Craft, J. (2001) Antinuclear antibodies, in Kelly’s Textbook of Rheumatology (Ruddy, S., Harris, E. D., and Sledge, C. B., eds.), Saunders, Philadelphia, PA, pp. 161–174.
Shlomchik, M. J., Madaio, M. P., Ni, D., Trounstein, M., and Huszar, D. (1994) The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180, 1295–1306.
Peng, S. L., Cappadona, J., McNiff, J. M., Madaio, M. P., Owen, M. J., Hayday, A. C., et al. (1998) Pathogenesis of autoimmunity in αβ T cell-deficient lupus-prone mice. Clin. Exp. Immunol. 111, 107–116.
Kofler, R., Perlmutter, R. M., Noonan, D. J., Dixon, F. J., and Theofilopoulos, A. N. (1985) Ig heavy chain variable region gene complex of lupus mice exhibits normal restriction fragment length polymorphism. J. Exp. Med. 162, 346–351.
Kotzin, B. L., Barr, V. L., and Palmer, E. (1985) A large deletion within the T-cell receptor β-chain gene complex in New Zealand white mice. Science 229, 167–171.
Noonan, D. J., Kofler, R., Singer, P. A., Cardenas, G., Dixon, F. J., and Theofilopoulos, A. N. (1986) Delineation of a defect in T cell receptor β genes of NZW mice predisposed to autoimmunity. J. Exp. Med. 163, 644–653.
Yanagi, Y., Hirose, S., Nagasawa, R., Shirai, T., Mak, T. W., and Tada, T. (1986) Does the deletion within T cell receptor β-chain gene of NZW mice contribute to autoimmunity in (NZB × NZW) F1 mice? Eur. J. Immunol. 16, 1179–1182.
Singer, P. A., McEvilly, R. J., Balderas, R. S., Dixon, F. J., and Theofilopoulos, A. N. (1988) T-cell receptor α-chain variable-region haplotypes of normal and autoimmune laboratory mouse strains. Proc. Natl. Acad. Sci. USA 85, 7729–7733.
Wilson, R. K., Lai, E., Concannon, P., Barth, R. K., and Hood, L. E. (1988) Structure, organization and polymorphism of murine and human T-cell receptor α and β chain gene families. Immunol. Rev. 101, 149–172.
Jouvin-Marche, E., Morgado, M. G., Trede, N., Marche, P. N., Couez, D., Hue, I., et al. (1989) Complexity, polymorphism, and recombination of mouse T-cell receptor α gene families. Immunogenetics 30, 99–104.
Klotz, J. L., Barth, R. K., Kiser, G. L., Hood, L. E., and Kronenberg, M. (1989) Restriction fragment length polymorphisms of the mouse T-cell receptor gene families. Immunogenetics 29, 191–201.
Theofilopoulos, A. N., Kofler, R., Singer, P. A., and Dixon, F. J. (1989) Molecular genetics of murine lupus models. Adv. Immunol. 46, 61–109.
Noonan, D. J., McConahey, P. J., and Cardenas, G. J. (1990) Correlations of autoimmunity with H-2 and T cell receptor β chain genotypes in (NZB × NZW) F2 mice. Eur. J. Immunol. 20, 1105–1110.
Hansen, T. H., Carreno, B. M., and Sachs, D. H. (1993) The major histocompatibility complex, in Fundamental Immunology (Paul, W. E., ed.), Raven Press, New York, pp. 577–628.
Choi, Y., Ramnath, V. R., Eaton, A. S., Chen, A., Simon-Stoos, K. L., Kleiner, D. E., et al. (1999) Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Clin. Immunol. 93, 34–45.
Balomenos, D., Martin-Caballero, J., Garcia, M. I., Prieto, I., Flores, J. M., Serrano, M., et al. (2000) The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med. 6, 171–176.
Lawson, B. R., Kono, D. H., and Theofilopoulos, A. N. (2002) Deletion of p21 (WAF-1/Cip1) does not induce systemic autoimmunity in female BXSB mice. J. Immunol. 168, 5928–5932.
Strasser, A., Whittingham, S., Vaux, D. L., Bath, M. L., Adams, J. M., Cory, S., et al. (1991) Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA 88, 8661–8665.
Bouillet, P., Metcalf, D., Huang, D. C., Tarlinton, D. M., Kay, T. W., Kontgen, F., et al. (1999) Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286, 1735–1738.
Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L. C., Coultas, L., Puthalakath, H., et al. (2002) BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415, 922–926.
Murga, M., Fernandez-Capetillo, O., Field, S. J., Moreno, B., Borlado, L. R., Fujiwara, Y., et al. (2001) Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15, 959–970.
Salvador, J. M., Hollander, M. C., Nguyen, A. T., Kopp, J. B., Barisoni, L., Moore, J. K., et al. (2002) Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16, 499–508.
Di Cristofano, A., Kotsi, P., Peng, Y. F., Cordon-Cardo, C., Elkon, K. B., and Pandolfi, P. P. (1999) Impaired Fas response and autoimmunity in Pten ± mice. Science 285, 2122–2125.
Suzuki, A., Yamaguchi, M. T., Ohteki, T., Sasaki, T., Kaisho, T., Kimura, Y., et al. (2001) T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 14, 523–534.
Yoshinaga, S. K., Zhang, M., Pistillo, J., Horan, T., Khare, S. D., Miner, K., et al. (2000) Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int. Immunol. 12, 1439–1447.
Prodeus, A. P., Goerg, S., Shen, L. M., Pozdnyakova, O. O., Chu, L., Alicot, E. M., et al. (1998) A critical role for complement in maintenance of self-tolerance. Immunity 9, 721–731.
O’Keefe, T. L., Williams, G. T., Davies, S. L., and Neuberger, M. S. (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274, 798–801.
Majeti, R., Xu, Z., Parslow, T. G., Olson, J. L., Daikh, D. I., Killeen, N., et al. (2000) An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103, 1059–1070.
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., and Sharpe, A. H. (1995) Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541–547.
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., et al. (1995) Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270, 985–988.
Bolland, S. and Ravetch, J. V. (2000) Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity 13, 277–285.
Le, L. Q., Kabarowski, J. H., Weng, Z., Satterthwaite, A. B., Harvill, E. T., Jensen, E. R., et al. (2001) Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14, 561–571.
Suzuki, H., Kundig, T. M., Furlonger, C., Wakeham, A., Timms, E., Matsuyama, T., et al. (1995) Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268, 1472–1476.
Nishimura, H., Nose, M., Hiai, H., Minato, N., and Honjo, T. (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141–151.
Wen, L., Roberts, S. J., Viney, J. L., Wong, F. S., Mallick, C., Findly, R. C., et al. (1994) Immunoglobulin synthesis and generalized autoimmunity in mice congenitally deficient in αβ(+) T cells. Nature 369, 654–658.
Wang, J. H., Avitahl, N., Cariappa, A., Friedrich, C., Ikeda, T., Renold, A., et al. (1998) Aiolos regulates B cell activation and maturation to effector state. Immunity 9, 543–553.
Nash, J. T., Taylor, P. R., Botto, M., Norsworthy, P. J., Davies, K. A., and Walport, M. J. (2001) Immune complex processing in C1q-deficient mice. Clin. Exp. Immunol. 123, 196–202.
Botto, M., Dell’Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., et al. (1998) Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19, 56–59.
Mackay, F., Woodcock, S. A., Lawton, P., Ambrose, C., Baetscher, M., Schneider, P., et al. (1999) Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med. 190, 1697–1710.
Gross, J. A., Johnston, J., Mudri, S., Enselman, R., Dillon, S. R., Madden, K., et al. (2000) TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404, 995–999.
Khare, S. D., Sarosi, I., Xia, X. Z., McCabe, S., Miner, K., Solovyev, I., et al. (2000) Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA 97, 3370–3375.
Krawczyk, C., Bachmaier, K., Sasaki, T., Jones, G. R., Snapper, B. S., Bouchard, D., et al. (2000) Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 13, 463–473.
Zhang, Y., Schlossman, S. F., Edwards, R. A., Ou, C. N., Gu, J., and Wu, M. X. (2002) Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc. Natl. Acad. Sci. USA 99, 878–883.
Hibbs, M. L., Tarlinton, D. M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., et al. (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301–311.
Nishizumi, H., Taniuchi, I., Yamanashi, Y., Kitamura, D., Ilic, D., Mori, S., et al. (1995) Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity 3, 549–560.
Cornall, R. J., Cyster, J. G., Hibbs, M. L., Dunn, A. R., Otipoby, K. L., Clark, E. A., et al. (1998) Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8, 497–508.
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., et al. (2001) Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411, 207–211.
Demetriou, M., Granovsky, M., Quaggin, S., and Dennis, J. W. (2001) Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733–739.
Sun, H., Lu, B., Li, R. Q., Flavell, R. A., and Taneja, R. (2001) Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat. Immunol. 2, 1040–1047.
Yaswen, L., Kulkarni, A. B., Fredrickson, T., Mittleman, B., Schiffman, R., Payne, S., et al. (1996) Autoimmune manifestations in the transforming growth factor-β1 knockout mouse. Blood 87, 1439–1445.
Gorelik, L. and Flavell, R. A. (2000) Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171–181.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Peng, S.L. (2004). Experimental Use of Murine Lupus Models. In: Perl, A. (eds) Autoimmunity. Methods in Molecular Medicine™, vol 102. Humana Press. https://doi.org/10.1385/1-59259-805-6:227
Download citation
DOI: https://doi.org/10.1385/1-59259-805-6:227
Publisher Name: Humana Press
Print ISBN: 978-1-58829-231-5
Online ISBN: 978-1-59259-805-2
eBook Packages: Springer Protocols